First Therapy Approved for HPV-Related Respiratory Disease

MedPage Today) — The FDA on Thursday approved the immunotherapy zopapogene imadenovec (Papzimeos) for adults with recurrent respiratory papillomatosis (RRP), a rare chronic disease driven by persistent human papillomavirus (HPV) infection.
This…